DCT
1:24-cv-01013
Novo Nordisk Inc v. Mylan Pharma Inc
General
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
SourcePACER
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
09/11/24 - 12/06/24 | 40% |
Plaintiff
Party
Attorney
Defendant
Party
Attorney